Neoplasms by Site Completed Phase 2 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00377520A Trial for Patients With Advanced/Recurrent Endometrial CancerTreatment